AI-enabled Site-Specific Integration Cell Line Development Platform


Cell line development (CLD) plays a pivotal role in determining the robustness and cost-effectiveness of downstream bioprocessing development. Great Bay Bio developed a proprietary AlfaCell® platform that applies Site-Specific Integration (SSI) technology and AI-enabled cell selection to accurately insert the target genes into specific “hot spot” within the genome of a host cell line. AlfaCell® platform significantly reduces time, effort, and cost that are associated with the development of high-performance mammalian cell lines.



Data and Model Collaboration

Data and Model Collaboration3

Strategic Partnership Models

tech-2 (1)

AlfaCell®RCB: Construction from DNA to high-yield and stable RCB

tech-2 (2)

AlfaCell® Out-licensing

tech-2 (3)

AlfaCell® Development: Develop your own cell line into a Site-Specific Integration (SSI) platform

tech-2 (4)

AlfaCell® Technology: Transfer of our patented technology

Interested In Our Technology Platforms?

Let's Partner up